A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Associate Director, Patient Services - HUB Operations

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNew York, NY, USAHybrid

About the Job

Requirements

  • A bachelor's degree and at least 7 years of experience in Patient Service Hub management within the biotech industry are required.
  • Relevant experience leading patient support Hub programs and complex product launches within the patient support space is required.
  • Experience managing complex and dynamic projects, programs, and teams in a fast-paced environment is required.
  • The role requires on-site work Monday, Tuesday, and Thursday; fully remote candidates are not considered.
  • An analytical mindset and experience directing and managing activities critical to both the home office and field sales are required.
  • A strong understanding of industry trends in the pharmaceutical patient services landscape is required.
  • A problem-solving mindset, a demonstrated lean-forward approach, and the ability to think critically are required.
  • The ability to influence decision makers and educate varied internal audiences on complex concepts is required.

Responsibilities

  • Support the design, development, and implementation of the Patient Services Hub, including workflow creation, process optimization, and technology integration.
  • Develop and implement strategies to continually enhance the patient and provider experience and address patient needs through regular benchmarking and ATU research.
  • Ensure compliance with applicable regulatory requirements and patient information privacy policies, including HIPAA regulations.
  • Serve as the primary point of contact for the Hub administrator and Patient Services operations, ensuring high service-delivery standards and optimal service levels.
  • Develop and monitor key performance metrics to assess program effectiveness and identify areas for improvement.
  • Analyze program processes and recommend improvements to efficiency and cost reduction without compromising quality of care.
  • Plan and execute training programs for Hub staff and internal teams on new procedures, systems, and patient support strategies.
  • Develop and implement metrics and key performance indicators to measure Hub performance, patient satisfaction, and program effectiveness.
  • Monitor and analyze Hub performance data, identify areas for improvement, and implement corrective actions as needed.
  • Collaborate with Field Reimbursement Managers and Market Access leadership on program needs across the portfolio.
  • Respond to and resolve broader, complex escalated issues.
  • Partner with the Director to develop and manage program improvements and optimizations across the portfolio.
  • Manage multiple projects in a fast-paced, deadline-driven entrepreneurial environment and adapt to change as needed.
  • Lead the establishment and growth of a new Patient Services Hub, building and managing its team and fostering collaborative relationships.
  • Provide ad hoc support to Field Access and Patient Service functions within the Market Access team as related to the Hub.

Desired Qualifications

  • Previous product launch experience, preferably in the central nervous system space.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs